These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 8052878

  • 21. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
    Fournel P, Robinet G, Thomas P, Souquet PJ, Léna H, Vergnenégre A, Delhoume JY, Le Treut J, Silvani JA, Dansin E, Bozonnat MC, Daurés JP, Mornex F, Pérol M, Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie.
    J Clin Oncol; 2005 Sep 01; 23(25):5910-7. PubMed ID: 16087956
    [Abstract] [Full Text] [Related]

  • 22. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L.
    Lung Cancer; 2004 Oct 01; 46(1):87-98. PubMed ID: 15364136
    [Abstract] [Full Text] [Related]

  • 23. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA.
    Semin Oncol; 1994 Jun 01; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [Abstract] [Full Text] [Related]

  • 24. Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity.
    Robert F, Childs HA, Spencer SA, Redden DT, Hawkins MM.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):136-47. PubMed ID: 10210553
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Wu KL, Zang Z, Zhao S.
    Radiother Oncol; 2004 May 01; 71(2):157-62. PubMed ID: 15110448
    [Abstract] [Full Text] [Related]

  • 31. Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer.
    Wendland MM, Sause WT.
    Semin Surg Oncol; 2003 May 01; 21(2):111-21. PubMed ID: 14508861
    [Abstract] [Full Text] [Related]

  • 32. The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis.
    Lee HW, Choi JH, Lim HY, Park JS, Kim HC, Kang S, Oh YT, Chun M, Sheen SS, Oh YJ, Park KJ, Hwang SC.
    Neoplasma; 2006 May 01; 53(1):30-6. PubMed ID: 16416010
    [Abstract] [Full Text] [Related]

  • 33. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct 01; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 34. [Recent progress in chemotherapy for advanced lung cancer].
    Negoro S, Fukuoka M.
    Gan To Kagaku Ryoho; 1995 Mar 01; 22(4):451-60. PubMed ID: 7887637
    [Abstract] [Full Text] [Related]

  • 35. Treatment of stage III non-small cell lung cancer with thoracic radiation therapy and simultaneous platinum chemotherapy.
    Bonomi P.
    Semin Oncol; 1994 Jun 01; 21(3 Suppl 6):101-8. PubMed ID: 8052869
    [Abstract] [Full Text] [Related]

  • 36. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
    Socinski MA.
    Clin Lung Cancer; 2004 Mar 01; 5(5):274-89. PubMed ID: 15086966
    [Abstract] [Full Text] [Related]

  • 37. [Concurrent chemoradiotherapy for stage III non-small cell lung cancer].
    Hou HL, Hao JL, Pang QS, Wang P.
    Zhonghua Yi Xue Za Zhi; 2010 Aug 03; 90(29):2068-70. PubMed ID: 21029648
    [Abstract] [Full Text] [Related]

  • 38. Chemoradiotherapy for lung cancer: current status and perspectives.
    Ohe Y.
    Int J Clin Oncol; 2004 Dec 03; 9(6):435-43. PubMed ID: 15616873
    [Abstract] [Full Text] [Related]

  • 39. [Neo-adjuvant chemotherapy of locally advanced non-small cell bronchial cancers].
    Pujol JL, Daurès JP, Godard P, Michel FB.
    Rev Pneumol Clin; 1994 Dec 03; 50(4):147-54. PubMed ID: 7724981
    [Abstract] [Full Text] [Related]

  • 40. Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence.
    O'Rourke N, Macbeth F.
    Clin Oncol (R Coll Radiol); 2010 Jun 03; 22(5):347-55. PubMed ID: 20427167
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.